A Look At Aehr Test Systems (AEHR) Valuation After New Silicon Photonics Customer Win
Aehr Test Systems AEHR | 52.16 51.50 | +17.69% -1.27% Pre |
Aehr Test Systems (AEHR) is back in focus after announcing a significant new customer, a global networking leader that has placed initial orders for silicon photonics test systems tied to hyperscale AI data center expansion.
The new silicon photonics customer announcement comes alongside sharp share price moves, with a 1-day share price return of 11.92% and a 7-day return of 36.29%. The 1-year total shareholder return is very large, and the 5-year total shareholder return exceeds 17x, pointing to strong momentum but also shifting expectations around growth and risk.
If AI infrastructure is on your radar, this is a good moment to see what else is moving in the space and review 36 AI infrastructure stocks
With AEHR now at US$44.32, a discount to the US$36.33 analyst target and a very large 1-year return already on the board, the key question is clear: is there still upside here, or is future growth already priced in?
Preferred Price-to-Sales of 25.5x: Is it justified?
At a last close of $44.32 with a very large 1 year total return and a P/S ratio of 25.5x, Aehr Test Systems is priced far above typical semiconductor peers.
The P/S ratio compares the company’s market value to its revenue, which is useful here because AEHR is currently unprofitable with a net loss of $8.856m on $53.249m of revenue. For growth focused semiconductor names, investors often watch P/S to gauge how much future revenue expansion is already reflected in the share price.
For AEHR, the current P/S of 25.5x stands against three clear reference points. It is well above the peer group average of 3.6x and also above the broader US Semiconductor industry average of 5.7x. In addition, Simply Wall St’s fair P/S estimate is 6.9x, a level the market could move toward if expectations cool or if revenue does not track the more optimistic scenarios being priced in.
Result: Price-to-Sales of 25.5x (OVERVALUED)
However, the current net loss of $8.856m, alongside a P/S of 25.5x, means any slowdown in revenue or AI related orders could quickly pressure sentiment.
Next Steps
With sentiment clearly split between strong past returns and a rich P/S, this is a good time to look at the underlying data yourself and decide how comfortable you are with the current setup. To see both sides of the story in one place, review the 1 key reward and 2 important warning signs
Looking for more investment ideas?
If AEHR feels fully priced, do not stop here. Use this momentum to scan other opportunities so you are not relying on a single story.
- Hunt for potential bargains by checking out companies that currently screen as 62 high quality undervalued stocks.
- Prioritise resilience by reviewing 67 resilient stocks with low risk scores that may better match your comfort with volatility and drawdowns.
- Spot lesser known opportunities early by scanning the screener containing 25 high quality undiscovered gems before they appear on everyone else’s radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
